Here’s a title for a GEO dataset we espied today: BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2. ACE2 is indeed reduced by BRD2 knockdown in the Calu-3 cells used in this unpublished study. We’ll add the data to our database shortly.
What other drugs/treatments
might reduce ACE2 levels? It’s easy to use our “Relevant Studies” tool to get
some clues: type “ACE2” in the identifiers box, choose “downregulated” under “Regulation”,
and choose “lung” as “Cell type.”
In terms of “do it at home”
approaches, it appears that increased selenium might do it. You’ll have to
check out the fine details in the underlying study to see if the levels used in
mice would be at all “reasonable” in humans: Dietary Selenium Levels Affect
Selenoprotein Expression and Support the Interferon-γ and IL-6 Immune Response
Pathways in Mice. That’s about it. The three other approaches suggested by
the Relevant Studies app are not exactly home-friendly: knockouts of TLR3,
RNase L, or transfection of mir-138.
Perhaps bizarrely, there’s
actually a study that links inadequate selenium to Covid-19 infection. The
sample size was fairly small (30 patients, 30 controls), but an impressive P-value
was derived (.0003): An exploratory study of selenium status in healthy
individuals and in patients with COVID-19 in a south Indian population: The
case for adequate selenium status.
We can eliminate the requirement
that the downregulation occur in the lung. In that case, we get 102 approaches!
In terms of drugs, there’s cabergoline, GSK3 inhibitors, dimethyl maleate, and
a long list of other drugs. Even after eliminating the “lung” requirement,
selenium is still the only potential DIY approach.
Of course, transcriptomic
results don’t always translate to proteomic results. In terms of proteomic studies,
only the aforementioned RNaseL KO is found in the database.
What might increase ACE2
levels? With the “lung” requirement, we see only two results, neither of which suggest that common drugs could lead to inadvertant ACE2 over-expression. Without the requirement, we get 115 results.
Interestingly, interferon-alpha treatment might not be recommended as a
Covid-19 preventative. Trametinib, metformin, resveratrol, ifn-kappa,
antibiotics, dexamethasone, cholesterol, low riboflavin (vitamin B2) levels, and
gold ion could also be contra-indicated for folks who are keen to avoid
Covid-19. Cholesterol in particular catches our eyes, as many viruses seem to
require it to carve out their little lipid-encased niches in or around the host
endoplasmic reticulum. Naturally, though, it’s questionable whether dietary
cholesterol alterations would have any effect on ACE2 levels in the human lung
(mouse hippocampi were examined in the study in question).
Hopefully, we needn’t point
out that everything above should be validated in the lab/field. It’s also worth
remembering that Covid-19 prevention and treatment are very, very different
subjects; potentially diametrically opposed! Both dexamethasone and interferons
have indeed been used as treatments for infected patients.
No comments:
Post a Comment